SELECT2: A Randomized Controlled Trial to Optimize Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 352 participants.

Also called NCT03876457

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 352 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03876457
Other papers using this trial's data
  • Anticoagulation Use and Endovascular Thrombectomy in Patients with Large Core Stroke: A Secondary Analysis of the SELECT2 Trial Annals of neurology, 2024-11 DOI, PubMed 39039739
  • Association of Ischemic Core Hypodensity With Thrombectomy Treatment Effect in Large Core Stroke: A Secondary Analysis of the SELECT2 Randomized Controlled Trial Stroke, 2025-06 DOI, PubMed 40151939
  • Cerebral Edema in Patients With Large Ischemic Core After Thrombectomy: A Secondary Analysis of SELECT2 Randomized Trial Stroke, 2026-06 DOI, PubMed 41906875
  • Endovascular Thrombectomy for Extracranial Internal Carotid Artery Occlusions With Large Ischemic Strokes: Insights From the SELECT2 Trial Neurology, 2025-02-25 DOI, PubMed 39869840
  • Endovascular thrombectomy plus medical care versus medical care alone for large ischaemic stroke: 1-year outcomes of the SELECT2 trial Lancet (London, England), 2024-02-24 DOI, PubMed 38346442
  • General vs Nongeneral Anesthesia for Endovascular Thrombectomy in Patients With Large Core Strokes: A Prespecified Secondary Analysis of SELECT2 Trial Neurology, 2025-07-22 DOI, PubMed 40570276
  • Sex-Based Differences in Endovascular Thrombectomy Outcomes for Large Ischemic Stroke: A SELECT2 Subanalysis Stroke, 2025-02 DOI, PubMed 39744837
  • Trial of Endovascular Thrombectomy for Large Ischemic Strokes The New England journal of medicine, 2023-04-06 DOI, PubMed 36762865 PubMed links an erratum for this paper. Erratum: PMID 38265667

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Australia, Canada, New Zealand, Spain, Switzerland (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03876457. Randomized; single masking; primary purpose treatment. Start 2019-10-11 (actual); primary completion 2022-11-20 (actual). Results posted on 2024-03-15.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
SELECT2: A Randomized Controlled Trial to Optimize Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke
Acronym
SELECT2
Condition
Acute Ischemic Stroke
Intervention (Device)
Endovascular Thrombectomy
Intervention (Other)
Medical Management
Lead sponsor
University Hospitals Cleveland Medical Center (class: other)
Collaborator
Stryker Neurovascular (class: industry)
Collaborator
The University of Texas Health Science Center, Houston (class: other)

Record details

Record id
cardio:ct-nct03876457
Content hash
b868c8a2c1168c9f1f55579b4c14abf330877a0fa8d40883cf4f2d13a7d36687